Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function

Immune Health Clinical Trial

Official title:
A Randomized, Double-blind, Controlled, Parallel-arm Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function in Healthy Adults

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.

Clinical Trial Description

Samples will be retained for possible analyses such as lactoferrin absorption, distribution, metabolism, and excretion (ADME) and gut microbiota. ;

Study Design

Related Conditions & MeSH terms

Immune Health

Clinical Trial Details

NCT number	NCT06012669
Study type	Interventional
Source	Midwest Center for Metabolic and Cardiovascular Research
Contact
Status	Completed
Phase	N/A
Start date	September 6, 2023
Completion date	December 27, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05595980` - The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults	N/A
Completed	`NCT04780867` - Psychological and Lifestyle Factors on Health Outcomes	N/A
Active, not recruiting	`NCT05059639` - Exploring the Role of Almonds in Enhancing Immune Strength	N/A
Recruiting	`NCT06067477` - Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups	N/A
Completed	`NCT05004454` - Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults	N/A
Completed	`NCT04733924` - Efficacy and Tolerability of Sensoril® in Improving Immunity and Thereby Reducing Incidence of Upper Respiratory Tract Infections	N/A
Completed	`NCT04713735` - Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections	N/A